CHINA PHARMA HOLDINGS INC (CPHI) Stock Price, Quote, News and Overview
NYSEARCA:CPHI - American Stock Exchange - US16941T3023 - Common Stock
CPHI Quote and Key Statistics
CHINA PHARMA HOLDINGS INC
NYSEARCA:CPHI (1/22/2025, 8:15:50 PM)
Premarket: 0.207 0 (-1.38%)0.2099
-0.01 (-2.82%)
CPHI Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.23% | ||
| ROE | -72.67% | ||
| Debt/Equity | 0.61 |
CPHI Performance and Technical Analysis
CPHI Ownership and Analysts
CPHI Latest News and Analysis
Top movers in Monday's after hours session
Which stocks are moving after the closing bell on Monday?
CPHI Stock Earnings: China Pharma Holding Reported Results for Q2 2024
China Pharma Holding just reported results for the second quarter of 2024.
CPHI Stock Earnings: China Pharma Holding Reported Results for Q1 2024
China Pharma Holding just reported results for the first quarter of 2024.
CPHI Stock Earnings: China Pharma Holding Reported Results for Q4 2023
China Pharma Holding just reported results for the fourth quarter of 2023.
About CPHI
Company Profile
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 231 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
Company Info
CHINA PHARMA HOLDINGS INC
2nd Floor, No. 17, Jinpan Road, Haikou
Haikou HAINAN 570216 CN
CEO: Zhilin Li
Employees: 231
Company Website: http://www.chinapharmaholdings.com
Investor Relations: http://www.chinapharmaholdings.com/index.htm
Phone: 8689866811730
CPHI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 74.14 | 715.77B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.04 | 357.84B | ||
| JNJ | JOHNSON & JOHNSON | 14.54 | 349.75B | ||
| MRK | MERCK & CO. INC. | 16.08 | 242.04B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.9 | 211.49B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.16 | 196.27B | ||
| PFE | PFIZER INC | 10.08 | 147.40B | ||
| SNY | SANOFI-ADR | 12.29 | 129.15B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.79 | 115.79B | ||
| ZTS | ZOETIS INC | 28.93 | 75.18B | ||
| GSK | GSK PLC-SPON ADR | 8.11 | 68.21B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 21.48 | 40.87B |